EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli

Fang Zhou, Kexiao Wang, Shuai Ji, Xiaochen Liao, Wenwen Zhang, Tieshan Teng, Li Wang iD, Qiming Li iD

Microbiology Spectrum · 2025-07 · 13 (7)

DOI: 10.1128/spectrum.01633-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025-07. Verfasst von Fang Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, Department of Clinical Laboratory, The First Affiliated …. Hauptthemen laut MEDLINE: Escherichia coli, Escherichia coli Infections, Anti-Bacterial Agents, Bacteriophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province (Henan Natural Science Foundation), China Postdoctoral Science Foundation, Projects for cellege students in Henan university.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the overuse of antibiotics has not yet been strictly limited in urban areas, drug-resistant Escherichia coli has become a fatal pressure for bacteremia treatment. Considering the outstanding performance of bacteriophages in vitro , bacteriophages may serve as an alternative to heal chronic refractory infections. In this study, a 49,890 bp double-stranded circular DNA phage, Henu8, was isolated and was able to lyse the group of E. coli strains tested in this study. Prominent biological characterization revealed that the highly adsorbed bacteriophage Henu8 could form a fully transparent plaque with a narrow translucent halo. The optimal multiplicity of infection of the bacteriophage Henu8 was 0.01, with a burst size of 275 PFU/cell. Genomic analysis revealed a G + C content of 44.17% Henu8, in which 65 open reading frames were located, which could be assigned as a new species in the genus Hanrivervirus of the subfamily Tempevirinae . The effective antibacterial ability and the obvious biofilm destruction and inhibition capability of phage Henu8 were observed. The time-killing assay demonstrated the synergetic potential of Henu8 with antibiotics in vitro for E. coli eradication. Henu8 has profound medicinal potential in a mouse bacteremia model. These studies indicate that Henu8 is a novel bacteriophage with therapeutic potential alone or in combination with antibiotics for clinical treatment. IMPORTANCE The findings described in this study constitute concrete evidence that it is possible to significantly synergize the antimicrobial activity of bacteriophages and antibiotics. We showed that the newly isolated potent bacteriophage Henu8 lyses Escherichia coli rapidly but tends to produce resistant bacteria. The bacteriophage Henu8 has synergistic antimicrobial effects with several antibiotics and is not susceptible to developing resistance. These results provide further evidence that bacterial resistance to phages arises, possibly at an adaptive cost to sensitivity to antibiotics. Therefore, the findings of this study are important for increasing the potential of phages for clinical applications and developing new approaches to improve their therapeutic efficacy against bacterial drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliEscherichia coli InfectionsAnti-Bacterial AgentsBacteriophagesAnimalsMiceBacteremiaPhage TherapyBiofilmsGenome, ViralBase CompositionDisease Models, Animal

Stichwörter der Autor:innen

E. colibacteriophage Henu8phage therapysynergistic antibacterial

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Henan Province Engineering Technology Research Center of Rapid-Accuracy Medical Diagnostics, Department of Clinical Laboratory, The First Affiliated Hospital of Henan University, Henan University, Kaifeng, China.
  • The Joint National Laboratory of Antibody Drug Engineering, Henan University, Kaifeng, China.
  • Department of Microbiology, College of Basic Medical Sciences, Henan University, Kaifeng, China.

ORCID-Profile: Li Wang, Qiming Li

Förderung

  • Natural Science Foundation of Henan Province (Henan Natural Science Foundation)
  • China Postdoctoral Science Foundation
  • Projects for cellege students in Henan university
  • Kaifeng science and technology development program
  • Henan science and technology development program projects
  • Provinces and ministries jointly built key projects of henan provincial health commussion
  • The platform construction fund of Henan Province EngineeringTechnology Research Center of Rapid-Accuracy Medical Diagnostics

Zitieren

APA

Zhou, F., Wang, K., Ji, S., Liao, X., Zhang, W., Teng, T., Wang, L., & Li, Q. (2025). The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli. Microbiology Spectrum, 13(7). https://doi.org/10.1128/spectrum.01633-24

Vancouver

Zhou F, Wang K, Ji S, Liao X, Zhang W, Teng T, et al. The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli. Microbiology Spectrum. 2025;13(7). doi:10.1128/spectrum.01633-24

BibTeX
@article{Zhou2025,
  author = {Zhou, Fang and Wang, Kexiao and Ji, Shuai and Liao, Xiaochen and Zhang, Wenwen and Teng, Tieshan and Wang, Li and Li, Qiming},
  title = {The virulent bacteriophage Henu8 as an antimicrobial synergist against Escherichia coli},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {7},
  doi = {10.1128/spectrum.01633-24}
}
Kostenlos starten →